As part of activities marking Cervical Cancer Awareness Month, the Marketing Team of the Corporate Affairs Directorate of the Authority organized a Cervical Cancer Awareness Health Talk and Panel Discussion on 16 January 2026 at the Ministry of Health Conference Room in Accra.
The programme focused on cervical cancer prevention, screening, and early detection, while highlighting the role of the National Health Insurance Scheme (NHIS) in supporting access to cervical cancer treatment, including approved screening methods, chemotherapy, and radiotherapy. It was disclosed that between 2023 and 2025, the NHIA processed claims totaling GH₵5,743,354.68 for the treatment of 5,649 NHIS members that had cervical cancer treatment.
Participants were educated on the various screening methods available for cervical cancer, including Visual Inspection with Acetic Acid (VIA), the Pap Smear, and Human Papillomavirus (HPV) testing. The panelists explained that individuals diagnosed through screening are subsequently placed on appropriate treatment and care.
The panel discussion was moderated by Ms. Shaniece Palm of the Corporate Affairs Department, with Dr. Abena Ekufua Esia-Donkoh, Deputy Director at CPC Cape Coast, and Ms. Doris Adjei, Deputy Director of the Nursing Service, serving as panelists.
In his opening remarks, the Director of Corporate Affairs, Mr. Oswald Essuah Mensah, encouraged participants to actively engage in the discussion and ask questions. He noted that NHIA had deliberately aligned itself with national and global efforts to raise awareness about cervical cancer, stressing the importance of informed conversations in early detection and prevention.
The Head of Communication, Ms. Faustina Dery, urged staff particularly women to prioritise regular cervical cancer screening. She also cautioned against unsafe practices involving the use of unverified substances and advised staff to seek professional medical guidance.
During the question-and-answer session, participants sought clarification on modes of transmission, HPV testing for men, and common misconceptions about cervical cancer. The panel clarified that although men do not have a cervix, they can carry HPV and may be tested through non-cervical samples. The panel also advised against the use of unapproved herbal medications.
The programme concluded with closing remarks by Mr. Oswald Essuah Mensah, who reaffirmed NHIA’s commitment to health education, disease prevention, and access to quality healthcare.
